A Prospective Randomized Placebo-Controlled Double Blind

Project: Research project

Description

A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal CD4+CD25+CD127lo/-FOXP3+ Regulatory T-cells [Tregs]) in Adolescents with Recent Onset Type 1 Dia
StatusActive
Effective start/end date6/1/163/30/20

Funding

  • Caladrius Biosciences Inc

Fingerprint

Regulatory T-Lymphocytes
Placebos
Clinical Trials
Safety